Excessive weight gain during peritoneal dialysis

Autor: C Chatatalsingh, Joanne M. Bargman, Dimitrios G. Oreopoulos, Maggie Chu, Stephen I. Vas, Shivinder S. Jolly

Publikováno v: The International Journal of Artificial Organs. 24:197-202

The authors carried out a retrospective chart review in 114 patients treated for at least two years at the Toronto Western Hospital Peritoneal Dialysis Unit and identified eight, who gained an “excessive” amount of weight equal to or greater than

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7086e81f16ad651dcceafe8e7ca51f5f
https://doi.org/10.1177/039139880102400405

Perfluorodecalin Corneal Toxicity: Five Case Reports

Autor: Shivinder S. Jolly, Andrew Apel, Garth A. Wilbanks, David S. Rootman, Robert G. Devenyi

Publikováno v: Cornea. 15:329-334

Perfluorodecalin is a perfluorocarbon liquid used intraoperatively in retinal detachment repair. It is usually removed at the end of the procedure; however, residual amounts may be retained when poor corneal clarity or intraocular hemorrhage obscures

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae1e97f3d90db44c0f7b0219bde1c4a
https://doi.org/10.1097/00003226-199605000-00017

C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on Dialysis: Results of a Randomized Clinical Trial

Autor: Francesco Locatelli, Rowan G. Walker, M. Formica, G. Choukroun, N. Kopyt, Paul C. Nader, U. Frei, Alan W. McMahon, A. Martinez Castelao, G. Papadakis, R. Burgos-Calderon, E. Imbasciati, A. Fine, Carmine Zoccali, Steven J. Rosansky, L. Frenken, Norman Muirhead, Paul E. Barre, Csaba P. Kovesdy, Frank C. Dougherty, I. C. Macdougall, G. Pylypchuk, J. Kwan, V. Esnault, George M. Nassar, Ulrich Beyer, Charmaine E. Lok, Robert Provenzano, R. Schmidt, D. Fischer, R. Solomon, D. Durand, I. MacPhee, R. Walker, V. Pichette, B. Stegmayr, Thomas A. Golper, Shivinder S. Jolly, C. Vela, Michèle Kessler, M. del Pino y Pino, M. Suranyi, F. de Alvaro, G. Sakellariou, T. Risler, Maurice Laville, Sean Murphy, J. E Marco Franco, P. Tam, K. Warr, S. Noble, G. Carpenito, P. C. Nader, Marcello Amato, G. Deferrari, H. R. Locay, C. Wijeyesinghe, C. Breen, Giuseppe Villa, Sheldon W. Tobe, Adeera Levin, C. Jacquot, G. P. Dragoun, P. Evenepoel, A. Balducci, R. Lafayette, Paolo Altieri, Fernando de Alvaro, J. Kraut, B. Faller, I. Papadakis, Bruce F. Culleton, D. Rodriguez Puyol, M. Annerstedt, C. Hagen, Kostas C. Siamopoulos, Rainer P. Woitas, F. Locatelli, L. Craver, Iain C. Macdougall, Peter G. Kerr, K. Harris, K. Hahn, Jeffrey G. Penfield, Bruce Spinowitz, Vassilis Vargemezis, E. Morales Ruiz, George A. Kaysen, Harold R. Locay, Edwina A. Brown

Background and objectives: This study examined the efficacy of C.E.R.A., a continuous erythropoietin receptor activator, for correcting anemia in patients who had chronic kidney disease (CKD) and were not on dialysis. Design, setting, participants, &

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9aa0d849595437aa1c34fe0f7e1c49d
https://europepmc.org/articles/PMC2390949/

The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease.

Autor: Johansen KL; Hennepin Healthcare, University of Minnesota, Minneapolis, Minnesota, USA. Electronic address: Kirsten.Johansen@hcmed.org., Cobitz AR; GSK, Collegeville, Pennsylvania, USA., Singh AK; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Macdougall IC; Renal Department, King's College Hospital, London, UK., Lopes RD; Duke Clinical Research Institute, Duke Health, Durham, North Carolina, USA., Obrador GT; Universidad Panamericana School of Medicine, Mexico City, Mexico., Kovesdy CP; Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Israni R; GSK, Collegeville, Pennsylvania, USA., Jha V; George Institute for Global Health, New Delhi, India; Faculty of Medicine, Imperial College, London, UK; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India., Okoro T; GSK, Collegeville, Pennsylvania, USA., Sprys M; GSK, Collegeville, Pennsylvania, USA., Jolly S; Clinical Research Solutions Inc, Waterloo, Canada., Lindsay AC; GSK, Collegeville, Pennsylvania, USA., Bhatt P; GSK, Collegeville, Pennsylvania, USA., Camejo RR; Value Evidence and Outcomes Department, GSK, Brentford, UK., Keeley T; Value Evidence and Outcomes Department, GSK, Brentford, UK., Cizman B; GSK, Collegeville, Pennsylvania, USA., Wheeler DC; Department of Renal Medicine, University College London, London, UK.

Publikováno v: Kidney international [Kidney Int] 2023 Jun; Vol. 103 (6), pp. 1180-1192. Date of Electronic Publication: 2023 Mar 02.

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.

Autor: Chonchol M; University of Colorado Health Science Center, Division of Renal Diseases and Hypertension, Denver, CO 80262, USA. michel.chonchol@uchsc.edu, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA

Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2009 Feb; Vol. 53 (2), pp. 197-207. Date of Electronic Publication: 2008 Dec 24.